Justin Garrison, DO
Family Medicine · Morristown, TNNPI 1841533429
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $24,938 of the $34,977 with a category attached, or 71.3%. 50 manufacturers reported payments, led by Merck at 56.2% of the total. Reporting peaked in 2021 at $12,726 and has fallen 87.6% since, to $1,580 in 2025. Among family medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 541 payments — averaging $64.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$20K
- Organon$7K
- Novo Nordisk$1K
- AbbVie$1K
- GSK$818
- AstraZeneca$751
- plus $4K from 44 others
What the payments were for
- Speaking & faculty fees$24,93871%
- Travel & lodging$1,5344%
- Food & beverage$8,46424%
- Education$410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$26,459
- FARXIGA$380
- AIRSUPRA$125
- TRELEGY ELLIPTA$122
- XARELTO$107
How this compares
$34,977 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 234 | $274,952 |
| EliquisApixaban | 256 | $181,598 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 199 | $138,238 |
| FarxigaDapagliflozin Propanediol | 150 | $136,825 |
| TrulicityDulaglutide | 83 | $111,470 |
| JardianceEmpagliflozin | 91 | $98,190 |
| XareltoRivaroxaban | 131 | $93,153 |
| MounjaroTirzepatide | 79 | $87,613 |
| LinzessLinaclotide | 108 | $73,139 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 76 | $60,476 |
| Abilify MaintenaAripiprazole | 23 | $48,858 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 54 | $46,522 |
| RybelsusSemaglutide | 36 | $40,375 |
| VraylarCariprazine Hcl | 26 | $36,450 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 39 | $32,050 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,348 | $315,328270 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $101 | $199,083162 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $751 | $197,943263 claims |
| PfizerEliquis | $413 | $181,598256 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $818 | $157,631239 claims |
| AbbVieLinzess, Vraylar, Ubrelvy | $1,261 | $126,991146 claims |
| Johnson & JohnsonXarelto | $329 | $93,153131 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $101 | $68,25134 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $333 | $32,05039 claims |
| MerckJanuvia, Belsomra | $19,658 | $26,89735 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $129 | $26,68656 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $59 | $17,69926 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Morristown
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
- Jerry PunchKnoxville$45K
- Christopher HollowayAntioch$41K
- Curtis JantziKingsport$39K
- Ellen ClelandChattanooga$38K
- Meredith SchweitzerAntioch$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.